Cargando…

Correction: Applications of radiomics‑based analysis pipeline for predicting epidermal growth factor receptor mutation status

Detalles Bibliográficos
Autores principales:	Liu, Zefeng, Zhang, Tianyou, Lin, Liying, Long, Fenghua, Guo, Hongyu, Han, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053477/ https://www.ncbi.nlm.nih.gov/pubmed/36991397 http://dx.doi.org/10.1186/s12938-023-01095-x

Ejemplares similares

Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status
por: Liu, Zefeng, et al.
Publicado: (2023)

Correction: Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes
por: Kharmate, Geetanjali, et al.
Publicado: (2016)

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma
por: Zhao, Wei, et al.
Publicado: (2020)

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
por: Yunxia, Zuo, et al.
Publicado: (2010)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Lu, Jiameng, et al.
Publicado: (2022)

Correction for Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx
Publicado: (2010)

Correction to: Epidermal stem cells in wound healing and their clinical applications
por: Yang, Ronghua, et al.
Publicado: (2020)

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance
por: Danilov, Alexey V., et al.
Publicado: (2018)

Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma
por: Kawazoe, Yusuke, et al.
Publicado: (2023)

Value of radiomics model based on multi-parametric magnetic resonance imaging in predicting epidermal growth factor receptor mutation status in patients with lung adenocarcinoma
por: Wang, Yuze, et al.
Publicado: (2021)

Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma
por: Jiang, Meilin, et al.
Publicado: (2022)

Correction to: Progress in studies of epidermal stem cells and their application in skin tissue engineering
por: Yang, Ronghua, et al.
Publicado: (2022)

Correction: The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells
por: Schönrath, Katharina, et al.
Publicado: (2013)

Evaluation of Epidermal Growth Factor Receptor 2 Status in Gastric Cancer by CT-Based Deep Learning Radiomics Nomogram
por: Guan, Xiao, et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma
por: Yang, Bin, et al.
Publicado: (2020)

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma
por: Huo, Ji-wen, et al.
Publicado: (2022)

Correction: Retraction: A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells
Publicado: (2019)

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2023)

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?
por: Wójcik, P, et al.
Publicado: (2017)

Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
por: Solanki, Hitendra S., et al.
Publicado: (2021)

Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer
por: Li, Yexing, et al.
Publicado: (2020)

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
por: Wang, Shuxing, et al.
Publicado: (2021)

Correction: LotuS: an efficient and user-friendly OTU processing pipeline
por: Hildebrand, Falk, et al.
Publicado: (2014)

Correction to: PhosPiR: an automated phosphoproteomic pipeline in R
por: Hong, Ye, et al.
Publicado: (2022)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
por: Kaito, Akio, et al.
Publicado: (2020)

Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Sharma, Saniya, et al.
Publicado: (2018)

Correction Notice: Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
Publicado: (2023)

Correction to: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
por: Chen, Gang, et al.
Publicado: (2020)

Correction: Correction: Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling Pathway
Publicado: (2017)

Correction to: Impact of concurrency on the performance of a whole exome sequencing pipeline
por: Dall’Olio, Daniele, et al.
Publicado: (2021)

Combination of (18)F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Li, Shen, et al.
Publicado: (2022)

Correction: Chemical Genomic-Based Pathway Analyses for Epidermal Growth Factor-Mediated Signaling in Migrating Cancer Cells
Publicado: (2014)

Correction: A review on advances in 18F-FDG PET/CT radiomics standardisation and application in lung disease management
por: Anan, Noushin, et al.
Publicado: (2022)

Correction: Harmonizing the pixel size in retrospective computed tomography radiomics studies
por: Mackin, Dennis, et al.
Publicado: (2018)

Correction: Radiomics-based prediction of FIGO grade for placenta accreta spectrum
por: Bartels, Helena C., et al.
Publicado: (2023)

Assessment of epidermal growth factor receptor status in glioblastomas
por: Zhu, Hui-Jun, et al.
Publicado: (2013)

Correction to: An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
por: Wells, Daria W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9m9ucuijijtngidblob49nr0d8